Tonix Pharmaceuticals Holding Management
Management criteria checks 3/4
Tonix Pharmaceuticals Holding's CEO is Seth Lederman, appointed in Oct 2011, has a tenure of 11.83 years. total yearly compensation is $4.58M, comprised of 14.7% salary and 85.3% bonuses, including company stock and options. directly owns 0.029% of the company’s shares, worth €3.37K. The average tenure of the management team and the board of directors is 5 years and 4.9 years respectively.
Key information
Seth Lederman
Chief executive officer
US$4.6m
Total compensation
CEO salary percentage | 14.7% |
CEO tenure | 11.8yrs |
CEO ownership | 0.03% |
Management average tenure | 5yrs |
Board average tenure | 4.9yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Mar 31 2023 | n/a | n/a | -US$123m |
Dec 31 2022 | US$5m | US$675k | -US$117m |
Sep 30 2022 | n/a | n/a | -US$112m |
Jun 30 2022 | n/a | n/a | -US$102m |
Mar 31 2022 | n/a | n/a | -US$98m |
Dec 31 2021 | US$8m | US$675k | -US$92m |
Sep 30 2021 | n/a | n/a | -US$80m |
Jun 30 2021 | n/a | n/a | -US$73m |
Mar 31 2021 | n/a | n/a | -US$64m |
Dec 31 2020 | US$4m | US$614k | -US$52m |
Sep 30 2020 | n/a | n/a | -US$46m |
Jun 30 2020 | n/a | n/a | -US$42m |
Mar 31 2020 | n/a | n/a | -US$34m |
Dec 31 2019 | US$1m | US$585k | -US$31m |
Sep 30 2019 | n/a | n/a | -US$31m |
Jun 30 2019 | n/a | n/a | -US$28m |
Mar 31 2019 | n/a | n/a | -US$29m |
Dec 31 2018 | US$1m | US$473k | -US$29m |
Sep 30 2018 | n/a | n/a | -US$24m |
Jun 30 2018 | n/a | n/a | -US$24m |
Mar 31 2018 | n/a | n/a | -US$23m |
Dec 31 2017 | US$576k | US$473k | -US$21m |
Sep 30 2017 | n/a | n/a | -US$23m |
Jun 30 2017 | n/a | n/a | -US$25m |
Mar 31 2017 | n/a | n/a | -US$30m |
Dec 31 2016 | US$765k | US$473k | -US$39m |
Compensation vs Market: Seth's total compensation ($USD4.58M) is above average for companies of similar size in the German market ($USD418.12K).
Compensation vs Earnings: Seth's compensation has been consistent with company performance over the past year.
CEO
Seth Lederman (65 yo)
11.8yrs
Tenure
US$4,580,167
Compensation
Dr. Seth Lederman, M. D., is a Co-Founder of Tonix Pharmaceuticals Holding Corp. (formerly, Krele Pharmaceuticals) and has been its Chairman, Chief Executive Officer, President and Director since October 7...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 11.8yrs | US$4.58m | 0.029% € 3.4k | |
CFO & Treasurer | 7.5yrs | US$1.24m | 0.00074% € 87.1 | |
Chief Operating Officer | 7.5yrs | US$1.39m | 0.000010% € 1.2 | |
Chief Medical Officer & Secretary | 6.4yrs | US$1.48m | 0.0037% € 439.3 | |
Executive Vice President of Translational Medicine | 3.3yrs | no data | no data | |
Executive Vice President of Research | no data | US$580.96k | no data | |
Executive Vice President of Product Development | no data | no data | no data | |
Executive Vice President of Experimental Chemistry | 3.6yrs | no data | no data | |
Executive Vice President of Infectious Disease Research & Development | 1.1yrs | no data | no data | |
Executive Vice President of Medical | less than a year | no data | no data |
5.0yrs
Average Tenure
61yo
Average Age
Experienced Management: TPM0's management team is seasoned and experienced (5 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 11.8yrs | US$4.58m | 0.029% € 3.4k | |
Independent Director | 4.9yrs | US$300.00k | 0.00020% € 23.6 | |
Independent Director | less than a year | no data | 0% € 0 | |
Independent Director | 5.5yrs | US$300.00k | 0% € 0 | |
Independent Director | 5.9yrs | US$300.00k | 0.00020% € 23.6 | |
Independent Director | 3.2yrs | US$300.00k | 0.00038% € 44.8 | |
Member of Scientific Advisory Board | no data | no data | no data | |
Independent Lead Director | 4.5yrs | US$320.00k | 0.00038% € 44.8 | |
Member of Scientific Advisory Board | 12.2yrs | no data | no data | |
Independent Director | 2.1yrs | US$300.00k | 0% € 0 |
4.9yrs
Average Tenure
65.5yo
Average Age
Experienced Board: TPM0's board of directors are considered experienced (4.9 years average tenure).